Pangenomic Health Inc.
Pangenomic Health Inc. (NARA.CN) Stock Competitors & Peer Comparison
See (NARA.CN) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NARA.CN | CA$0.30 | -25.00% | 4.2M | -1.43 | -CA$0.21 | N/A |
| VHI.TO | CA$6.95 | -0.43% | 439.5M | 69.50 | CA$0.10 | N/A |
| CARE.TO | CA$5.15 | +0.10% | 345.7M | -17.15 | -CA$0.30 | N/A |
| KSI.TO | CA$3.30 | -4.62% | 316.1M | -165.00 | -CA$0.02 | N/A |
| AIDR.CN | CA$0.56 | +0.00% | 48.4M | -3.56 | -CA$0.16 | N/A |
| TRUE.CN | CA$0.51 | -1.92% | 38.5M | -2.68 | -CA$0.19 | N/A |
| HS.CN | CA$0.53 | +3.92% | 29M | -3.31 | -CA$0.16 | N/A |
| UDOC.CN | CA$0.13 | +44.44% | 11.2M | -3.25 | -CA$0.04 | N/A |
| RYAH.CN | CA$0.03 | +0.00% | 11.2M | -0.15 | -CA$0.17 | N/A |
| DMED.CN | CA$0.10 | +0.00% | 9.2M | -5.00 | -CA$0.02 | N/A |
Stock Comparison
NARA.CN vs VHI.TO Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, VHI.TO has a market cap of 439.5M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while VHI.TO trades at CA$6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas VHI.TO's P/E ratio is 69.50. In terms of profitability, NARA.CN's ROE is +1.62%, compared to VHI.TO's ROE of +0.03%. Regarding short-term risk, NARA.CN is less volatile compared to VHI.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NARA.CN.Check VHI.TO's competition here
NARA.CN vs CARE.TO Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, CARE.TO has a market cap of 345.7M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while CARE.TO trades at CA$5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas CARE.TO's P/E ratio is -17.15. In terms of profitability, NARA.CN's ROE is +1.62%, compared to CARE.TO's ROE of -0.23%. Regarding short-term risk, NARA.CN is less volatile compared to CARE.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NARA.CN.Check CARE.TO's competition here
NARA.CN vs KSI.TO Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, KSI.TO has a market cap of 316.1M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while KSI.TO trades at CA$3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas KSI.TO's P/E ratio is -165.00. In terms of profitability, NARA.CN's ROE is +1.62%, compared to KSI.TO's ROE of -0.04%. Regarding short-term risk, NARA.CN is less volatile compared to KSI.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NARA.CN.Check KSI.TO's competition here
NARA.CN vs AIDR.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, AIDR.CN has a market cap of 48.4M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while AIDR.CN trades at CA$0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas AIDR.CN's P/E ratio is -3.56. In terms of profitability, NARA.CN's ROE is +1.62%, compared to AIDR.CN's ROE of -3.04%. Regarding short-term risk, NARA.CN is less volatile compared to AIDR.CN. This indicates potentially lower risk in terms of short-term price fluctuations for NARA.CN.Check AIDR.CN's competition here
NARA.CN vs TRUE.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, TRUE.CN has a market cap of 38.5M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while TRUE.CN trades at CA$0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas TRUE.CN's P/E ratio is -2.68. In terms of profitability, NARA.CN's ROE is +1.62%, compared to TRUE.CN's ROE of -3.04%. Regarding short-term risk, NARA.CN is less volatile compared to TRUE.CN. This indicates potentially lower risk in terms of short-term price fluctuations for NARA.CN.Check TRUE.CN's competition here
NARA.CN vs HS.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, HS.CN has a market cap of 29M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while HS.CN trades at CA$0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas HS.CN's P/E ratio is -3.31. In terms of profitability, NARA.CN's ROE is +1.62%, compared to HS.CN's ROE of -1.34%. Regarding short-term risk, NARA.CN is less volatile compared to HS.CN. This indicates potentially lower risk in terms of short-term price fluctuations for NARA.CN.Check HS.CN's competition here
NARA.CN vs UDOC.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, UDOC.CN has a market cap of 11.2M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while UDOC.CN trades at CA$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas UDOC.CN's P/E ratio is -3.25. In terms of profitability, NARA.CN's ROE is +1.62%, compared to UDOC.CN's ROE of +62.39%. Regarding short-term risk, NARA.CN is less volatile compared to UDOC.CN. This indicates potentially lower risk in terms of short-term price fluctuations for NARA.CN.Check UDOC.CN's competition here
NARA.CN vs RYAH.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, RYAH.CN has a market cap of 11.2M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while RYAH.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas RYAH.CN's P/E ratio is -0.15. In terms of profitability, NARA.CN's ROE is +1.62%, compared to RYAH.CN's ROE of +14.95%. Regarding short-term risk, NARA.CN and RYAH.CN have similar daily volatility (0.00).Check RYAH.CN's competition here
NARA.CN vs DMED.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, DMED.CN has a market cap of 9.2M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while DMED.CN trades at CA$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas DMED.CN's P/E ratio is -5.00. In terms of profitability, NARA.CN's ROE is +1.62%, compared to DMED.CN's ROE of +5.27%. Regarding short-term risk, NARA.CN is less volatile compared to DMED.CN. This indicates potentially lower risk in terms of short-term price fluctuations for NARA.CN.Check DMED.CN's competition here
NARA.CN vs TELE.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, TELE.CN has a market cap of 7.6M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while TELE.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas TELE.CN's P/E ratio is -0.13. In terms of profitability, NARA.CN's ROE is +1.62%, compared to TELE.CN's ROE of +1.60%. Regarding short-term risk, NARA.CN and TELE.CN have similar daily volatility (0.00).Check TELE.CN's competition here
NARA.CN vs LYNX.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, LYNX.CN has a market cap of 6.4M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while LYNX.CN trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas LYNX.CN's P/E ratio is -0.29. In terms of profitability, NARA.CN's ROE is +1.62%, compared to LYNX.CN's ROE of -1.35%. Regarding short-term risk, NARA.CN and LYNX.CN have similar daily volatility (0.00).Check LYNX.CN's competition here
NARA.CN vs AIML.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, AIML.CN has a market cap of 5.9M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while AIML.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas AIML.CN's P/E ratio is -1.17. In terms of profitability, NARA.CN's ROE is +1.62%, compared to AIML.CN's ROE of -3.31%. Regarding short-term risk, NARA.CN and AIML.CN have similar daily volatility (0.00).Check AIML.CN's competition here
NARA.CN vs NDAT.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, NDAT.CN has a market cap of 3.7M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while NDAT.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas NDAT.CN's P/E ratio is -4.50. In terms of profitability, NARA.CN's ROE is +1.62%, compared to NDAT.CN's ROE of -0.34%. Regarding short-term risk, NARA.CN is less volatile compared to NDAT.CN. This indicates potentially lower risk in terms of short-term price fluctuations for NARA.CN.Check NDAT.CN's competition here
NARA.CN vs LITE.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, LITE.CN has a market cap of 2M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while LITE.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas LITE.CN's P/E ratio is -0.50. In terms of profitability, NARA.CN's ROE is +1.62%, compared to LITE.CN's ROE of -6.63%. Regarding short-term risk, NARA.CN and LITE.CN have similar daily volatility (0.00).Check LITE.CN's competition here
NARA.CN vs CBP.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, CBP.CN has a market cap of 1.7M. Regarding current trading prices, NARA.CN is priced at CA$0.30, while CBP.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas CBP.CN's P/E ratio is -1.00. In terms of profitability, NARA.CN's ROE is +1.62%, compared to CBP.CN's ROE of +0.17%. Regarding short-term risk, NARA.CN and CBP.CN have similar daily volatility (0.00).Check CBP.CN's competition here
NARA.CN vs TMED.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, TMED.CN has a market cap of 929.3K. Regarding current trading prices, NARA.CN is priced at CA$0.30, while TMED.CN trades at CA$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas TMED.CN's P/E ratio is -0.30. In terms of profitability, NARA.CN's ROE is +1.62%, compared to TMED.CN's ROE of +0.80%. Regarding short-term risk, NARA.CN is less volatile compared to TMED.CN. This indicates potentially lower risk in terms of short-term price fluctuations for NARA.CN.Check TMED.CN's competition here
NARA.CN vs CGN.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, CGN.CN has a market cap of 895.9K. Regarding current trading prices, NARA.CN is priced at CA$0.30, while CGN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas CGN.CN's P/E ratio is -0.13. In terms of profitability, NARA.CN's ROE is +1.62%, compared to CGN.CN's ROE of +0.96%. Regarding short-term risk, NARA.CN and CGN.CN have similar daily volatility (0.00).Check CGN.CN's competition here
NARA.CN vs KETA.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, KETA.CN has a market cap of 532.7K. Regarding current trading prices, NARA.CN is priced at CA$0.30, while KETA.CN trades at CA$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas KETA.CN's P/E ratio is -2.00. In terms of profitability, NARA.CN's ROE is +1.62%, compared to KETA.CN's ROE of +0.01%. Regarding short-term risk, NARA.CN and KETA.CN have similar daily volatility (0.00).Check KETA.CN's competition here
NARA.CN vs MEND.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, MEND.CN has a market cap of 0. Regarding current trading prices, NARA.CN is priced at CA$0.30, while MEND.CN trades at CA$0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas MEND.CN's P/E ratio is N/A. In terms of profitability, NARA.CN's ROE is +1.62%, compared to MEND.CN's ROE of -1.68%. Regarding short-term risk, NARA.CN and MEND.CN have similar daily volatility (0.00).Check MEND.CN's competition here
NARA.CN vs WTEQ.CN Comparison April 2026
NARA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NARA.CN stands at 4.2M. In comparison, WTEQ.CN has a market cap of 0. Regarding current trading prices, NARA.CN is priced at CA$0.30, while WTEQ.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NARA.CN currently has a P/E ratio of -1.43, whereas WTEQ.CN's P/E ratio is 2.00. In terms of profitability, NARA.CN's ROE is +1.62%, compared to WTEQ.CN's ROE of -1.70%. Regarding short-term risk, Volatility data is not available for a full comparison. NARA.CN has daily volatility of 0.00 and WTEQ.CN has daily volatility of N/A.Check WTEQ.CN's competition here